Year: 2005
Type: letter
Abstract: cyclophosphamide, methotrexate, fluorouracil (CMF).Data supporting the occurrence of 'cures '.Breast Cancer Res Treat 1999;53:209e15.3. Howell, on behalf of the ATAC Trailists' Group.A. The ATAC ('Arimidex', tamoxifen alone or in combination) trial in postmenopausal women with breast cancer-updated efficacy results base on a median follow-up of 5 years.
Source: International Journal of Surgery
Author: Donald Berry
Institution: The University of Texas MD Anderson Cancer Center
Language: English
Subfield: Cancer Research
Domain: Life Sciences
Open Access status: bronze
OpenAlex ID: W2128245115